Merck

Showing 15 posts of 360 posts found.

Merck and Schering-Plough propose shareholder settlement

July 28, 2009
Sales and Marketing MA, Merck

Merck and Schering-Plough's legal battles with their shareholders may be approaching a truce. Two class action lawsuits earlier this year …

Merck makes progress on vaccines supply issues

July 24, 2009
Manufacturing and Production Merck

Merck & Co's new manufacturing facility in Durham, North Carolina, is on schedule to start production of vaccines in the …

Merck signs anticoagulant collaboration

July 17, 2009
Research and Development, Sales and Marketing Merck, cv

Merck has continued the trend of big pharma companies signing on the dotted line with small biotech outfits in a …

Merck takes aim at neglected tropical diseases

June 25, 2009
Research and Development, Sales and Marketing Africa, Merck, Orphan

Merck & Co is participating in two projects designed to help improve healthcare in Africa. The pharma giant will join …

AstraZeneca and Merck launch early stage trial collaboration

June 3, 2009
Research and Development AZ, AstraZeneca, Cancer, Merck

Merck and AstraZeneca have begun an unprecedented collaboration to bring together the clinical trials of two early stage cancer medicines.The …

Merck acquires rights to atrial fibrillation candidate

April 16, 2009
Research and Development, Sales and Marketing Merck, cv

Merck has signed an agreement with Vancouver-based Cardiome Pharma to develop its new treatment for atrial fibrillation vernakalant.Merck will pay …

2-in-1: Merck and Schering-Plough

April 8, 2009
Research and Development, Sales and Marketing Merck, Schering-Plough, merger, pharma

The Merck and Schering-Plough merger creates a new industry giant to challenge Pfizer in terms of its scale and annual …

Merck’s mega-merger will mark a return to sales growth

March 16, 2009
Sales and Marketing MA, Merck

As a standalone company, Merck & Co. faces a tough future of declining sales. Analysts Datamonitor forecast that the merger …

Merck unveils $41 billion takeover of Schering-Plough

March 9, 2009
Sales and Marketing MA, Merck

Merck is to acquire Schering-Plough for $41.1 billion, creating a new industry giant to challenge Pfizer in terms of its …

Schering-Plough invests in Scotland drug discovery centre

February 6, 2009
Research and Development Merck, Scotland

Schering-Plough is to invest around $30 million in its early drug discovery work in Scotland. The company is investing a …

Merck to streamline management structure

October 24, 2008
Sales and Marketing Merck

Merck has announced a new round of job cuts and restructuring in a bid to update its business model and …

Experts play down Inergy cancer risk

September 5, 2008
Sales and Marketing Merck, cv

Heart specialists have told patients to continue taking Schering-Plough and Merck's cholesterol-lowering drug Inergy, despite a study indicating that it …

Schering-Plough to buy Organon for 11 billion euros

March 21, 2007
Sales and Marketing Merck, Schering-Plough

Schering-Plough is to buy Organon BioSciences by the end of this year, in an €11 billion cash deal.The acquisition will …

Cholesterol drugs boost Schering-Plough

February 9, 2007
Sales and Marketing Merck, Schering-Plough

A 60% increase in sales of its cholesterol drugs franchise has helped Schering-Plough to post strong growth for 2006.Ezetrol and …

Markets stunned as Merck withdraws blockbuster Vioxx

September 30, 2004
Merck, Vioxx

Merck has taken the pharmaceutical world by surprise by announcing the immediate withdrawal of its blockbuster arthritis pain drug Vioxx …

Latest content